REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kant Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kant Drugs Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Kant Drugs Private Limited is an unlisted company, incorporated on 05/02/2001. It has its registered office in the State of Uttar Pradesh, India. Company's corporate identification number (CIN) is U24232UP2001PTC025855 and registration number is 025855.

Legal Address
Bharat Ashramraja Bazar Lucknow
Lucknow; Uttar Pradesh; Postal Code: 226003

Contact Details: Purchase the Kant Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Kant Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Kant Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Kant Drugs Private Limited report to view the information.
Incorporation Date:
February 05, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Kant Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.51%▲
Total operating revenue
3.86%▲
Operating profit (EBIT)
-0.92%▼
EBITDA
-1.58%▼
Net Profit (Loss) for the Period
40.16%▲
Total Assets
14.82%▲
Total Equity
14.02%▲
Operating Profit Margin (ROS)
-0.53%▼
Net Profit Margin
2.33%▲
Return on Equity (ROE)
2.3%▲
Debt/Equity
2.99%▲
Quick Ratio
0.23%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo